ProfileGDS4132 / 220166_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 46% 34% 52% 44% 40% 37% 32% 42% 45% 44% 39% 36% 41% 53% 44% 36% 36% 45% 46% 45% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101120.92246
GSM201543Muscle PCOS pioglitazone 12178.286434
GSM201544Muscle PCOS pioglitazone 161140.90752
GSM201545Muscle PCOS pioglitazone 201123.03944
GSM201829Muscle PCOS pioglitazone 231111.77440
GSM201830Muscle PCOS pioglitazon 25197.086437
GSM201831Muscle PCOS pioglitazone 27175.958632
GSM201832Muscle PCOS pioglitazone 31107.06342
GSM201833Muscle PCOS pioglitazone 41111.19645
GSM201834Muscle PCOS pioglitazone 81114.38844
GSM201835Muscle PCOS after pioglitazone 10287.523639
GSM201836Muscle PCOS after pioglitazone 12280.450636
GSM201837Muscle PCOS after pioglitazone 16289.225341
GSM201838Muscle PCOS after pioglitazone 202131.70453
GSM201839Muscle PCOS after pioglitazone 232106.50544
GSM201840Muscle PCOS after pioglitazone 25287.961836
GSM201841Muscle PCOS after pioglitazone 27277.901136
GSM201842Muscle PCOS after pioglitazone 3296.880245
GSM201843Muscle PCOS after pioglitazone 42115.40546
GSM201844Muscle PCOS after pioglitazone 82112.57445